Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed + Vinorelbine in HER2-negative Metastatic Breast Cancer
NCT03242616Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2017
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of pemetrexed in breast cancer, sponsored by Seoul National University Hospital. Started Feb 2017; status: completed.
02
Drugs
pemetrexed
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03242616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03242616.